Professor Erik Stroes, Amsterdam UMC, The Netherlands, explores the changing landscape in the cardiovascular arena, including growing understanding of the role of elevated Lp(a) as a causal risk factor and its inclusion in routine cardiovascular risk assessment.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
